Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost–utility are yet to be proved
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/4/988/573371/mdr009.pdf
Reference9 articles.
1. Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information;Soini;Ann Oncol,2011
2. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity;Fiore;Ann Surg Oncol,2006
3. Outcomes of patients with advanced soft-tissue sarcomas treated in clinical trials vs expanded access programs: a decade of experience with single-agent trabectedin;Demetri;J Clin Oncol,2010
4. Trabectedin (Tr) as single agent for advanced soft tissue sarcomas (STS) failing standard of care: interim analysis of 1572 patients in an expanded access program study;Samuels;J Clin Oncol,2010
5. Growth rate of lung metastases and s-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas;Blomqvist;Br J Cancer,1996
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom;Sarcoma;2014
2. Cost-utility and expected value of perfect information related to trabectedin in the treatment of metastatic soft-tissue sarcoma: the publicly funded comments explored;Annals of Oncology;2011-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3